These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8306831)

  • 1. Five-year follow-up study of the fat clearance technique in colorectal carcinoma.
    Scott KW; Grace RH; Gibbons P
    Dis Colon Rectum; 1994 Feb; 37(2):126-8. PubMed ID: 8306831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance.
    Scott KW; Grace RH
    Br J Surg; 1989 Nov; 76(11):1165-7. PubMed ID: 2688803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.
    Haboubi NY; Clark P; Kaftan SM; Schofield PF
    J R Soc Med; 1992 Jul; 85(7):386-8. PubMed ID: 1378498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
    Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
    Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node harvest in Dukes' A cancer pathologist may need to consider fat dissolving technique: an observational study.
    Saklani AP; Udy T; Chandrasekaran TV; Davies M; Beynon J
    ScientificWorldJournal; 2012; 2012():919464. PubMed ID: 22649327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetone clearance of mesocolic or mesorectal fat increases lymph node yield and may improve detection of high-risk Stage II colorectal cancer patients.
    Leung CAW; Fazzi GE; Melenhorst J; Rennspiess D; Grabsch HI
    Colorectal Dis; 2018 Nov; 20(11):1014-1019. PubMed ID: 29989291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study.
    Haboubi NY; Abdalla SA; Amini S; Clark P; Dougal M; Dube A; Schofield P
    Int J Colorectal Dis; 1998; 13(2):99-102. PubMed ID: 9638496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
    Choi HJ; Choi YY; Hong SH
    Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apical node metastasis independently predicts poor survival in Dukes C colorectal cancer.
    Ang CW; Tweedle EM; Campbell F; Rooney PS
    Colorectal Dis; 2011 May; 13(5):526-31. PubMed ID: 20070342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of location of lymph node metastases in colorectal cancer.
    Shida H; Ban K; Matsumoto M; Masuda K; Imanari T; Machida T; Yamamoto T
    Dis Colon Rectum; 1992 Nov; 35(11):1046-50. PubMed ID: 1425048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?
    Cianchi F; Messerini L; Palomba A; Boddi V; Perigli G; Pucciani F; Bechi P; Cortesini C
    Dis Colon Rectum; 1997 Oct; 40(10):1170-5; discussion 1175-6. PubMed ID: 9336111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ; Li XP; Liu WF; Li GM
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.